Home / Pfizer Inc. (PFE)

Pfizer Inc. (PFE) Technical Analysis

Updated: 2026-06-16 09:25 UTC · Last close: 26.00 (-0.80%) · Support: 25.86 · Resistance: 26.04
Pfizer Inc. (PFE) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
⬇️ Support
25.86
⬆️ Resistance
26.04
🚀 Bullish Trigger
a clean close above 26.05 would strengthen the upside continuation case.
🔺 Technical Setup
Pattern
Triangle Compression / SYM / UP
State
Active
Trigger
25.89
Target
28.32
Risk / Invalid
25.34
Compression
81%
🎯 Decision Map
The nearest decision zone is framed by support around 25.44 and resistance near 26.05. The chart still needs to reclaim resistance to improve meaningfully, while any loss of support would keep weakness in control. Pattern invalidation sits near 28.78, so a violation there would materially change the current setup narrative.
📊 Technical Summary
At a glance
Trend
Mixed
Momentum
Neutral
Range
52% of 52W range
Key Zone
25.86 / 26.04
Pfizer Inc. (PFE) closed at 26.00 (-0.80%). Medium-term tone has softened, but price remains above MA200. Momentum stays positive (+2.65%); 52W position: 51% of range; and Volatility: ATR14 1.90%. RSI(14) stands around 50.2, which keeps the momentum picture broadly balanced. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD is positioned above the signal line, supporting a still constructive momentum backdrop. The MACD histogram remains positive, although upside momentum is not accelerating further.
🔺
Setup: Pattern Triangle breakout is active after price reclaimed the trigger zone.
•
Holding above 25.89 keeps the breakout structure healthier.
⚠️
Risk: A loss of 25.34 would weaken the setup.
•
Projection target sits near 28.32.
🎯
Key levels: Key levels The nearest decision zone is framed by support at 25.86 and resistance at 26.04.
⚠️
Risk: A move through resistance would improve the short-term technical tone, while a loss of support would weaken the current structure.
💼 Fundamentals Snapshot
Source: sec
💼 Business Lens
QUALITY VIEW
Financial quality snapshot
Financial context is mixed
📈 Growth: Moderate 💰 Profit: Positive 💵 Cash: Mixed 🛡 Balance: Mixed
• Quarterly revenue is still growing, but the pace is cooling from earlier highs.
• Quarterly profitability is positive, though margins are not especially strong.
💵 Revenue
14.45B
📈 Net Income
2.69B
🧮 EPS (Basic)
0.47
🏢 Company
Pfizer Inc.
🏷 Sector
Healthcare
🧩 Industry
Pharma
Compare with related stocks
Same sector and industry ideas for deeper research
AbbVie (ABBV) technical analysisAstrazeneca (AZN) technical analysisBristol-Myers Squibb Company (BMY) technical analysisJohnson & Johnson (JNJ) technical analysisELI LILLY & Co (LLY) technical analysisMerck & Co (MRK) technical analysisTeva Pharmaceutical Industries (TEVA) technical analysis
WOI OPEN ADVANCED ANALYSIS WORKSPACE
Note: This is an algorithmic technical snapshot (not financial advice).
PFE Chart